Biotech News

MATERIALISE AANDELENINKOOPPROGRAMMA

Materialise (MTLS)Materialise2026-06-25 13:46 ESTCompany update

Leuven – 20 april 2026 – 22h00 CET Gereglementeerde informatie 1 Materialise rapporteert over de voortgang van haar op 30 oktober 2025 aangekondigde aandeleninkoopprogramma. 20 april 2026 – Materialise NV (Euronext: MTLS) (Nasdaq: MTLS) (“Materialise”) (“de Vennootschap”) maakt hierbij

Open original release

Related news

Materialise

Materialise is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States